12-56752228-G-A

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_000946.3(PRIM1):​c.71C>T​(p.Ser24Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000689 in 1,451,290 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: not found (cov: 30)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

PRIM1
NM_000946.3 missense

Scores

4
15

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 3.52
Variant links:
Genes affected
PRIM1 (HGNC:9369): (DNA primase subunit 1) The replication of DNA in eukaryotic cells is carried out by a complex chromosomal replication apparatus, in which DNA polymerase alpha and primase are two key enzymatic components. Primase, which is a heterodimer of a small subunit and a large subunit, synthesizes small RNA primers for the Okazaki fragments made during discontinuous DNA replication. The protein encoded by this gene is the small, 49 kDa primase subunit. [provided by RefSeq, Jul 2008]
HSD17B6 (HGNC:23316): (hydroxysteroid 17-beta dehydrogenase 6) The protein encoded by this gene has both oxidoreductase and epimerase activities and is involved in androgen catabolism. The oxidoreductase activity can convert 3 alpha-adiol to dihydrotestosterone, while the epimerase activity can convert androsterone to epi-androsterone. Both reactions use NAD+ as the preferred cofactor. This gene is a member of the retinol dehydrogenase family. [provided by RefSeq, Aug 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.25098506).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PRIM1NM_000946.3 linkc.71C>T p.Ser24Phe missense_variant Exon 1 of 13 ENST00000338193.11 NP_000937.1 P49642

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PRIM1ENST00000338193.11 linkc.71C>T p.Ser24Phe missense_variant Exon 1 of 13 1 NM_000946.3 ENSP00000350491.5 P49642

Frequencies

GnomAD3 genomes
Cov.:
30
GnomAD4 exome
AF:
6.89e-7
AC:
1
AN:
1451290
Hom.:
0
Cov.:
30
AF XY:
0.00000139
AC XY:
1
AN XY:
720740
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000167
GnomAD4 genome
Cov.:
30

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.091
T
BayesDel_noAF
Benign
-0.37
CADD
Uncertain
23
DANN
Uncertain
0.97
DEOGEN2
Benign
0.014
T;.
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.067
FATHMM_MKL
Uncertain
0.78
D
LIST_S2
Uncertain
0.92
D;D
M_CAP
Benign
0.021
T
MetaRNN
Benign
0.25
T;T
MetaSVM
Benign
-0.92
T
MutationAssessor
Benign
2.0
M;.
PrimateAI
Uncertain
0.55
T
PROVEAN
Benign
-2.3
N;N
REVEL
Benign
0.074
Sift
Benign
0.18
T;T
Sift4G
Benign
0.061
T;.
Polyphen
0.023
B;.
Vest4
0.24
MutPred
0.47
Gain of catalytic residue at Q25 (P = 0.0274);Gain of catalytic residue at Q25 (P = 0.0274);
MVP
0.53
MPC
0.44
ClinPred
0.70
D
GERP RS
3.8
Varity_R
0.27
gMVP
0.22

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

No publications associated with this variant yet.

Other links and lift over

hg19: chr12-57146012; API